|
C1ORF27 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62825308791525E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.14686038443779E-13 |
| Normal-vs-Stage2 |
1.32399999996924E-06 |
| Normal-vs-Stage3 |
3.17190718135407E-12 |
| Normal-vs-Stage4 |
6.70929978241475E-10 |
| Stage1-vs-Stage2 |
5.275800E-01 |
| Stage1-vs-Stage3 |
1.719570E-01 |
| Stage1-vs-Stage4 |
6.449800E-01 |
| Stage2-vs-Stage3 |
1.620350E-01 |
| Stage2-vs-Stage4 |
3.854600E-01 |
| Stage3-vs-Stage4 |
5.491800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.33066907387547E-16 |
| Normal-vs-AfricanAmerican |
3.370600E-04 |
| Normal-vs-Asian |
5.4587999676059E-09 |
| Caucasian-vs-AfricanAmerican |
2.248200E-01 |
| Caucasian-vs-Asian |
7.033600E-01 |
| AfricanAmerican-vs-Asian |
4.654400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.00960392560523E-11 |
| Normal-vs-Female |
1.63469238145808E-12 |
| Male-vs-Female |
9.820600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.12627701504198E-12 |
| Normal-vs-Age(41-60Yrs) |
4.83835194131643E-13 |
| Normal-vs-Age(61-80Yrs) |
5.08889996808648E-09 |
| Normal-vs-Age(81-100Yrs) |
9.760000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.922000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.448200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.090400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.320800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.149000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.000000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.218200E-03 |
| Classical-VS-Follicular |
2.733400E-01 |
| Classical-VS-Other |
3.115600E-01 |
| Classical-VS-Normal |
1.73105973999554E-12 |
| Tall-VS-Follicular |
3.516800E-03 |
| Tall-VS-Other |
9.031800E-01 |
| Tall-VS-Normal |
1.4827028493869E-11 |
| Follicular-VS-Other |
2.407800E-01 |
| Follicular-VS-Normal |
1.36230000002957E-06 |
| Other-VS-Normal |
4.835100E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.63919988693806E-11 |
| Normal-vs-N1 |
5.65020030762753E-10 |
| N0-vs-N1 |
5.054400E-01 |
|
|
